Alcon says demand seen resuming when underlying conditions normalize, could see improvement in late 2020

Q1 operating loss -28 million usd.q1 sales 1.8 billion usd.q1 diluted eps loss 0.12 usd.decline in global demand for surgical procedures will negatively impact q2 results.taking decisive actions to maintain global supply chain and control expenses and cash flow.unable to provide an estimate for financial results for full year 2020.customer demand is expected to resume when underlying conditions normalize and gradually lead to an improvement in back half of year.
ALC Ratings Summary
ALC Quant Ranking